is semaglutide or tirzepatide better for inflammation Ozempic, Mounjaro, Zepbound | Do they reduce Inflammation? Macrodosing GLP-1: The Risks of

The potential risks include digestive discomfort, gas, and bloating. They can also reduce the absorption of certain medications like lithium, certain antidepressants, digoxin, diabetes medications, bile acid sequestrants, and carbamazepine

Pregnant or breastfeeding women, and those planning to become pregnant, should not use this treatment

Although substantial weight loss can reduce pathological joint loading and systemic inflammation, the direct pharmacological effects on synovial fibroblastsattenuating their inflammatory signalling and fibrotic activation may offer an additional, disease-modifying and analgesic mechanism that targets the local synovial environment, driving pain and structural progression

Meeting BMI Requirements for Prescription Weight Loss Medication FDA-approved GLP-1 medications for weight loss are typically indicated for: Adults with obesity, defined as a body mass index of 30 or higher Adults with overweight, defined as a BMI of 27 or higher, who also have at least one weight-related medical condition A healthcare provider can confirm whether these criteria apply to your situation